N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors
CA 2525764 C · Owner: Ksander, Gary Michael · Inventors: Vedananda, Thalaththani Ralalage; Ksander, Gary Michael
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of the formula (I) provide pharmacological agents which bind to Peroxisome Proliferator-Activated Receptors (PPARs). Accordingly the , com-pounds , of the instant invention are useful for the treatment of conditions mediated by , the PPAR receptor activity in mammals. Such conditions include dyslipidemia hy-perlipidemia, hypercholesteremia, atherosclerosis hypertriglyceridemia, heart failure, myocardial infarction vascular diseases, cardiovascular diseases hypertension, obe-sity, inflammation, arthritis cancer, Alzheimer's disease, skin disorders respiratory, diseases, ophthalmic disorders inflammatory bowel diseases, ulcerative colitis, Crohn's disease, and conditions in which …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 19, 2004 and granted July 17, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 19, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 19, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.